Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Laxmi DentalNSE:LAXMIDENTL -4.96%16 Debt-to-EBITDA is 0.21 as of Mar. 2026, which is 43% below its 10-year median of 0.37. GuruFocus rates NSE:LAXMIDENTL with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 472 Medical Devices & Instruments companies, Laxmi Dental ranks better than 80.08% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Laxmi Dental's Debt-to-EBITDA or its related term are showing as below:
NSE:LAXMIDENTL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -14.08 Med: 0.37 Max: 3.58
Current: 0.28
During the past 5 years, the highest Debt-to-EBITDA Ratio of Laxmi Dental was 3.58. The lowest was -14.08. And the median was 0.37.
NSE:LAXMIDENTL's Debt-to-EBITDA is ranked better than 80.08% of 472
companies
in the Medical Devices & Instruments industry
Industry Median: 1.64
vs NSE:LAXMIDENTL: 0.28
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Laxmi Dental Debt-to-EBITDA Related Terms
Laxmi Dental Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Laxmi Dental's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:LAXMIDENTL vs ISRG, BDX, MDLN: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Laxmi Dental's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laxmi Dental Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Laxmi Dental's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Laxmi Dental's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Laxmi Dental (NSE:LAXMIDENTL) has a Debt-to-EBITDA of 0.21 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Laxmi Dental. This is 43% below median its historical median of 0.37. According to the industry distribution chart, Laxmi Dental ranks #94 out of 472 companies in the Medical Devices & Instruments industry, placing it in the top 19.9%.
Is Laxmi Dental's Debt-to-EBITDA too high?
Laxmi Dental's current Debt-to-EBITDA of 0.21 is 43% below median its 10-year median of 0.37. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.64. Laxmi Dental's value of 0.21 is 87.2% below this industry median. Based on the distribution chart, Laxmi Dental ranks #94 out of 472 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Laxmi Dental has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Laxmi Dental's Debt-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Laxmi Dental ranks #94 out of 472 companies for Debt-to-EBITDA. This places Laxmi Dental in the top 20% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 1.64. Laxmi Dental's value of 0.21 is 87.2% below this benchmark. While the company's 10-year median is 0.37 vs. the industry median of 1.64, Laxmi Dental has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.64, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laxmi Dental's current Debt-to-EBITDA of 0.21 is 87.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Laxmi Dental. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laxmi Dental's current Debt-to-EBITDA is 0.21, which is 43% below median its own 10-year median of 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laxmi Dental stock overvalued right now?
Laxmi Dental (NSE:LAXMIDENTL) has a current Debt-to-EBITDA of 0.21. The current Debt-to-EBITDA is 0.21, which is 43% below median its 10-year median of 0.37 and 87.2% below the Medical Devices & Instruments industry median of 1.64. Laxmi Dental's overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Laxmi Dental (NSE:LAXMIDENTL), the current Debt-to-EBITDA is 0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Laxmi Dental Ltd is an end-to-end integrated dental products company. Its products include custom-made crowns and bridges, branded dental products such as clear aligners, thermoforming sheets, and aligner-related products as a part of aligner solutions, and paediatric dental products. The Group has three reportable segments: Laboratory Business segment comprises dental prostheses, such as metal-free crowns & bridges, Porcelain Fused to Metal (PFM) Crowns and Bridges, and Dentures. The Aligners Business segment comprises dental aligners, Retainers, Raw Materials for Aligners, Sport Guards, Night Guards, and Sleep Apnea Devices. The Other Business segment comprises Dental distribution products used in Dental Laboratory, Dental Clinical Services, and Dental Educational Courses.
16GF Score
Get the complete analysis for NSE:LAXMIDENTL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LAXMIDENTL has been successfully added to your 
